Hematology/Oncology

Top Story

Topical imiquimod may be effective alternative to surgery for melanoma in situ

April 25, 2017

Topical imiquimod cream may be an effective treatment for patients with melanoma in situ who are not candidates for surgery, according to long-term study outcomes published in Dermatologic Surgery.

Researchers conducted a retrospective chart review of 12 white patients with biopsy-proven melanoma in situ (seven men; average age, 79 years) who were treated with topical 5% imiquimod cream between 2004 and 2015 at the dermatology section of Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.

In the Journals Plus

ASCO issues recommendations on second-line hormonal therapy for castration-resistant prostate cancer

April 25, 2017
A castrate state should be maintained indefinitely in men who develop castration-resistant prostate cancer despite castrate levels of testosterone, according to a…
FDA News

FDA grants fast track designation to tazemetostat for follicular lymphoma

April 25, 2017
The FDA granted fast track designation to tazemetostat for the treatment of patients with relapsed or refractory follicular lymphoma, according to the drug’s…
In the Journals

Donor age, sex not associated with survival of patients receiving transfusions

April 25, 2017
Survival is not influenced by the age and sex of blood donors among patients receiving blood transfusion, and blood allocation does not need to consider these factors…
In the Journals

Gallbladder cancer rates fall in men; late-stage diagnosis rates on the rise

April 25, 2017
Gallbladder cancer rates have continued to decrease among men in recent years, but do not show the same trend among women, and the rate of late-stage diagnosis increased…
More News Headlines »
CME

Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?

This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.

It is estimated that 76,380 new cases of melanoma will be diagnosed in the United Stated in 2017, with approximately…
More »
Video
Meeting News

VIDEO: Cappelli discusses autoimmune complications from cancer therapy

April 8, 2017
More »
Featured
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting

CME

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement